IHH Healthcare invests in TibaRay to transform cancer care with precision radiotherapyJanuary 29, 2026
TibaRay pioneers FLASH radiotherapy with proprietary linear accelerator technology, delivering radiation over 400 times faster than conventional methods while maintaining ultra-high precision for improved treatment outcomes.
IHH Healthcare has made a strategic investment in TibaRay, a US based medical technology company developing next-generation radiation therapy. The investment reinforces the group’s commitment to clinical excellence, patient safety, and transformative advancements.
This breakthrough technology aligns closely with IHH’s ambition to catalyze next-level care through meaningful innovation, strategic partnerships and powerful synergies. The investment also supports IHH’s broader transformation agenda to futureproof care and advances its Centres of Excellence strategy across oncology, cardiology, and orthopedics. TibaRay is pioneering a novel approach to radiotherapy through its proprietary linear accelerator technology which enables FLASH therapy, delivering radiation at ultra-high speeds – up to over 400 times faster than current technologies – with a high degree of precision. By significantly shortening treatment time and improving dose control, the technology has the potential to reduce any unnecessary radiation exposure to surrounding healthy tissue, increase treatment precision and efficacy while largely enhancing overall treatment experience for patients. This revolutionary technology was built upon years of research and over a dozen background patents by leading institutions in the United States particle-accelerator physics field, including Stanford University, SLAC National Accelerator Laboratory, and Arizona State University. Its exclusive know-how enables the building of the most power efficient compact linear accelerator, delivering ultra-rapid treatment that paves the way for FLASH therapy. As part of the collaboration, IHH will work with TibaRay on clinical evaluation, knowledge exchange and future deployment opportunities, strengthening the group's efforts cancer care capabilities across key markets. Delivering clinical excellence and advancing oncology care IHH has a strong track record of pioneering advanced cancer treatments across Asia. It is the first private healthcare provider in the region to offer proton therapy in Singapore and the first to explore upright photon therapy. This commitment is further reinforced through the group’s continued investments in state-of-the-art medical technologies such as the Linear Accelerator (LINAC) platforms and Gamma Knife radiosurgery, across its network in Singapore, Malaysia and India. The investment in TibaRay builds on a series of strategic initiatives to advance oncology innovation, including partnerships with Lucence and Leo Cancer Care, reflecting IHH’s disciplined and long-term approach to advancing cancer care. In 2019, IHH invested in Lucence through its Innovation Fund to support precision oncology diagnostics and has since deployed the genomic test across its labs in Singapore, Hong Kong, Malaysia and India. Lucence’s advanced diagnostic capabilities using liquid biopsy enhance early cancer screening and support clinicians in selecting more targeted treatments. In 2024, IHH became the first private healthcare group in Asia to join the Upright Photon Alliance, a global research consortium led by Leo Cancer Care alongside Mayo Clinic, Cone Health, OncoRay, and Centre Léon Bérard. In 2025, IHH expanded its collaboration and became an equity investor in Leo Cancer Care. In 2025, IHH launched its first Research Grant & Innovation Sandbox program among its global employees and clinicians to accelerate clinical research and pilot projects aimed at improving patient outcomes, focusing on areas such as oncology and chronic disease. More recently, it launched its Global Incubator Program to engage healthcare innovators and eco-system partners to develop solutions that can transform patient care. Collectively, these milestones underscore IHH’s longstanding commitment to advancing oncology care through deep clinical expertise, strategic partnerships and the responsible adoption of emerging technologies. |
EXPLORE FURTHER
|
PM Anwar Ibrahim launches National Heart Institute (IJN) University CollegeGovernment pledges full assistance for underprivileged students from 2026 onwards, adding 1,500 educational places
|
|
Amcor pioneers sustainable healthcare packaging revolution balancing innovation and regional needsSelangor facility set to transform APAC medical packaging supply chains
|
|
Vantive expands recycling programs across Southeast Asia and Pacific to cut medical wasteHome dialysis patients and hospitals join recycling programs in Malaysia, Thailand, Australia, New Zealand
|
|
UM Specialist Centre sets new standard in child diabetes care and smart ward innovationStrengthening Indonesian ties, driving medical tourism growth and regional healthcare leadership.
|
|
IHH Healthcare unveils bold new brand identitySetting its sights on integrated care, innovation, and sustainable partnerships to reshape the future of global healthcare delivery
|
|
Novo Nordisk expands KL office, reaffirms commitment to patient careAdvancing diabetes and obesity care: A commitment to excellence
|
|
KL Wellness City (KLWC) celebrates Chinese New Year with 75 elderly residentsKuala Lumpur International Hospital: 40% complete, opening Q3 2026
|
|
Huawei Matepad 12X and watch D2 arrive in MalaysiaExperience advanced health and productivity with Huawei’s latest innovative devices
|
|
Experience ultimate style and comfort with ECCO’s BIOM infinite sneakersInnovative design merges premium textiles and leather for unmatched flexibility
|
|
Perak Community Specialist Hospital appoints new Board of VisitorsNew BOV members to enhance community ties and healthcare services
|
|
Global report: Pharma multinationals underuse local content and social mediaPharma multinationals focus on home-country culture
|
|
Sophea Fertility Centre opens with New Zealand delegation visitInclusive, women-centric, and Muslim-friendly fertility care takes centre stage in Malaysia
|
|
Illumina and ScienceVision selected as sequencing technology partners for MyGenom projectMyGenom project to sequence 10,000 Malaysian genomes
|
|
Pantai Hospital (KL) introduces Outpatient Parenteral Antimicrobial Therapy (OPAT)Outpatient IV antimicrobial therapy eliminates need for extended hospitalization
|
|
Maaedicare fundraiser ball delivers RM500,000 boost for kidney, cardiac patientsSupporting free dialysis, heart health services, and free healthcare at 'Klinik Amal Percuma' for 256 patients
|
|
National Heart Institute (IJN) introduces Evolut FX device to treat aortic stenosisAddressing the needs of patients with small aortic annulus
|
|
Learn to save lives: Join our basic life support (BLS) courseDamai Pain Care & Wellness, in collaboration with Universiti Malaysia Sabah, offers BLS course led by AHA-certified instructors
|
|
Duopharma Biotech explores collaboration in halal pharmaceuticals at Doha roundtablePromising potential highlighted for bilateral relations between Malaysia - Qatar
|
|
Regency Specialist Hospital enters Malaysian Book of Records with diabetes screening campaign3,148 participants screened within three days
|
|
Sunway Medical Centre launches CSR radiotherapy program for cancer in SarawakSarawak ranks as the state with the 5th highest cancer incidence rates
|
|
EncoreMed shines brights at APHM conference, redefining healthcare with unified hospital digital solutionReducing hospital congestion by 50%
|
|
DKSH offers support to shelter home for children50 volunteers dedicate their efforts to create a comfortable environment
|
|
New ERT Nexviazyme approved for treatment of Pompe diseaseImproving lung function, walking distance, and muscle strength
|
|
Aurelius Healthcare and Rizman Ruzaini enhance staff uniforms across departments13 carefully crafted sets for easy identification
|
|
Taking quality lumbar support to new heightsWorld's first cordless massage chair debuts on the peak of Mount Kinabalu
|
|
DKSH Malaysia - Botrem partner to revolutionize skin rehabilitationTargeted solutions for persistent allergies
|
|
Duopharma Biotech - Owen Mumford partners to distribute medical devicesDiabetes and eye care products to be distributed as part of the agreement
|
|
Columbia Asia sets foot in Bukit JalilSeven-story hospital offering 96 ward beds and multi-specialties
|
|
Sunway Medical Centre Velocity introduces robotic surgery serviceA minimally invasive alternative to laparoscopic surgery
|
|
Danone Malaysia - the first food company to be certified B CorporationAdvocate of Iron Deficiency Anaemia (IDA) among Malaysian children
|
|
Preserving female cancer patients' fertility via cryopreservationIdeal for girls pre-puberty and women in reproductive age
|
|
Monurol (Fosfomycin Trometamol) receives DCA approval for transrectal prostate biopsy in adult menNew indication of perioperative antibiotic prophylaxis
|
|
Roche-MUIS announce funding for breast cancer patientsAccess to neoadjuvant therapy for HER-2 positive breast cancer patients
|
|
5-year-old Khaivan gains hearing ability through cochlear implant surgeryAudiolab's hearing solutions bring hope to those with hearing loss
|
|
Mahkota Medical Centre earns CCPC accreditation for breast cancerRM250 million investment towards healthcare transformation
|
|
UMW Toyota's generous donation bolsters cancer society's vital servicesExpanding cancer care reach and access
|
